Status:

COMPLETED

Depakote ER Therapy for Mania Comorbid With Substance Abuse

Lead Sponsor:

Creighton University

Collaborating Sponsors:

Abbott

Conditions:

Bipolar Disorder

Mania

Eligibility:

All Genders

19-65 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to ascertain whether Depakote ER (Divalproex ER) has efficacy in the treatment of patients with bipolar disorder in the manic phase, who also have comorbid substance abuse...

Detailed Description

This study will be performed in male and female subjects with a diagnosis of bipolar disorder in the manic phase of the illness who also have a comorbid diagnosis of substance abuse. This population i...

Eligibility Criteria

Inclusion

  • Ages 19 - 65.
  • Diagnosis of mania with comorbid substance confirmed by Structured Clinical Interview for DSM-IV.
  • Comorbid diagnoses of anxiety and/or personality disorders are permitted.
  • Ability to provide signed informed consent.
  • Stable general medical health.
  • Ability to attend outpatient research clinic.

Exclusion

  • Dangerous to self or others.
  • Pregnancy, inability or unwillingness to use approved methods of birth control.
  • Inability or unwillingness to provide signed informed consent.
  • Diagnosis of schizophrenia, major depressive disorder.
  • Inability to attend outpatient research clinic.
  • Medical conditions, which would preclude use of Depakote.
  • Need for ongoing treatment with medication other than Depakote ER, such as antipsychotic medication.
  • Medical instability defined as likelihood of needing to change prescription medication during the course of the study.

Key Trial Info

Start Date :

March 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00208195

Start Date

March 1 2004

End Date

November 1 2007

Last Update

December 14 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Creighton University Psychiatry Research Center

Omaha, Nebraska, United States, 68131